Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: Joseph Strohsahl who wrote (1377)	6/7/1999 9:41:00 AM
From: John S. Baker	Read Replies (1) \| Respond to of 1510

I have not given up on IMNR, and keep reminding myself that it is a multiple-product (therapy) company with several other useful products in the testing pipeline. But I find it a weird quirk of fate that the testing of Remune, a therapy which is supposed to keep people from dying of AIDS, is halted because not enough people are dying of AIDS. Something circular in that discussion, but I can't point it out right away. But of course it's good news for the AIDS patients who are still alive. JSb.